# Presentation: 785546

## August 20, 2003

**Focus Area 14:****Immunization and Infectious Diseases Progress Review**

## Immunization and Infectious Disease Objectives

**Immunization objectives**
**	****14-23****	****Vaccination in day care, grades K and 1**
**	****14-24****	****Fully immunized children**
**Plus others on **
**	****Disease prevalence****	****     Children and vaccination**
**	****Provider practice ****	****     Immunization registries**
**	****High-risk adults****	****     Adverse events**
**	****Vaccine safety **

## Immunization and Infectious Disease Objectives

**Infectious Disease objectives**
**	****14-10****	****Identification of persons with chronic Hepatitis C.**
**	****14-15****	****Prevention services for International travelers.**
**     ****Plus others on **
**	****Hepatitis A, B, and C ****	****	****   Bacterial meningitis**
**	****Peptic ulcer hospitalizations****	****   Pneumococcal infections ****	****   Antibiotics use ****	****       ****	****   Meningococcal disease   ****	****   Hospital-acquired infections****	****   Lyme disease ****	****	****  Anti-microbial use in ICU’s****	****   Group B streptococcal ****	****	****	****	****	****   disease**
**.**
**	****	**
**	****	**

## Immunization and Infectious Disease Objectives

**Tuberculosis objectives**
**   ****	****Tuberculosis**
**	****Curative therapy for tuberculosis**
**   ****	****Treatment for high-risk persons**
**	****Timely laboratory confirmation**

## Morbidity Profile

| Disease |    Average prevalence 
20th Cent. cases | 2000 cases | Target |
| --- | --- | --- | --- |
| Measles | 503,282 | 37 | 0 |
| Diphtheria | 175,885 | 1 | 0 |
| Mumps  | 152,209 | 238 | 0 |
| Pertussis  | 147,271 | 8,296 | 2,000 |
| Rubella  | 47,745 | 14 | 0 |
| H. Influenzae, type b | 20,000  | 167  | 0  |
| Polio (paralytic)  | 16,316 | 0 | 0 |
| Tetanus | 1,314 | 22 | 0 |
| Congenital Rubella Syndrome  | 823 | 3 | 0 |

## Vaccine-specific coverage rates among pre-school aged children

**DTP(3+)**

**MMR(1+)**

**Polio (3+)**

**Hib (3+)**

**Hep**** ****B (3+)**

**Varicella (1+)**

- Note:  Children in the USIS and NHIS were 24-35 months of age.  Children in the NIS were 19-35 months of age.
- Source: USIS (1967-1985), CDC, Division of Immunization, NHIS (1991-1993) CDC, NCHS, and NIS (1994-December 2002), CDC, NIP and NCHS; No data from 1986-1990 due to cancellation of USIS because of budget reductions

**2010 Target**

**Vaccine-specific coverage rates among pre-school aged children**

**Percent**

## Universally Recommended Vaccination Coverage Among Children 19-35 Months, 2002

**White, Not Hispanic**

**Black, Not Hispanic**

**Hispanic **

**American Indian / Alaskan Native **

**Asian**

**Universally Recommended Vaccination Coverage Among Children 19-35 Months, 2002**

- I 95% Confidence interval.  §  Data are statistically unreliable.
- Source:  NIS, CDC, NIP and NCHS.

**Percent**

**Percent**

**Percent**

**Percent**

**2010 Target**

**Native Hawaiian/ Other Pacific Islander **

**Multiple Race **

**Obj. 14-22**

**§**

**§**

**§**

## Universally Recommended Vaccination Coverage Among Children 19-35 Months, 2002

**White, ****Not Hispanic**

**Black, **
**Not Hispanic**

**Hispanic **

**American Indian / Alaskan Native **

**Asian **

**‡ **Developmental objective.  Target has not been determined.
- I 95% Confidence interval. §  Data are statistically unreliable.
- Source:  NIS, CDC, NIP and NCHS.

**Universally Recommended Vaccination Coverage Among Children 19-35 Months, 2002**

**DTP (4+) **

**DTP (3+)**

**Percent**

**Percent**

**Percent**

**4:3:1:3:3 Series**

**2010 Target**

**PCV(3+)****‡**

**Percent**

**Native Hawaiian/ Other Pacific Islander **

**Multiple Race **

**Obj. 14-22**

**§**

**§**

**§**

**§**

**§**

**§**

**(2001)**

**(2002)**

## Influenza Vaccination Coverage During the Past 12 Months, Among Adults 65 Years and Older

- Note: Percent receiving vaccine is estimated per Influenza season, using the January-June interviews only.
- Source:  NHIS, CDC, NCHS.

**2010 Target**

**Influenza Vaccination Coverage During the Past 12 Months, Among Adults 65 Years and Older**

**Percent**

**1988**

**1990**

**1992**

**1994**

**1996**

**1998**

**2000**

**Obj. 14-29a**

**2002**

## Pneumococcal Vaccination Coverage Ever Received Among Adults 65 Years and Older

**†**** **Data are preliminary.
- Source:  NHIS*, *CDC, NCHS.

**White**

**African American**

**Hispanic**

**2010 Target**

**Asian**

**Total**

**Pneumococcal Vaccination Coverage Ever Received Among Adults 65 Years and Older**

**Percent**

**Obj. 14-29b**

**†**

## Hepatitis A Incidence

**Hepatitis A Incidence**

**† **2002 Data are preliminary.
- Source: NNDSS, CDC, EPO.** **

**Cases per 100,000**

**1980**

**1985**

**1990**

**1995**

**2000**

**2010 Target**

**Obj. 14-6**

**2002**

## Hepatitis A Incidence

**Hepatitis A Incidence**

**† **2002 Data are preliminary.
- Source: NNDSS, CDC, EPO.** **

**Cases per 100,000**

**1980**

**1985**

**1990**

**1995**

**2000**

**2010 Target**

**Obj. 14-6**

**2002**

**19 years and older**

**Less than 19 years old**

## Hepatitis B Incidence

- Source: NNDSS, CDC, EPO.

**Estimated cases per 100,000**

**19-39 years**

**40 years and older**

**Less than19 years**

**Obj. 14-3**

**1990**

**2002**

**2000**

**1998**

**1996**

**1994**

**1992**

**1991 ACIP recommendations**
**	****(for infant vaccination schedule)**

## Hepatitis B Incidence

- Source: NNDSS, CDC, EPO.

**Estimated cases per 100,000 (log-scale)**

**19-39 years**

**40 years and older**

**Less than19 years**

**Obj. 14-3**

**1990**

**2002**

**2000**

**1998**

**1996**

**1994**

**1992**

## Hepatitis B Incidence, 2001

**Hepatitis B Incidence, 2001**

**American Indian/ **
**Alaska Native **

- I 95% Confidence interval.
- Source: NNDSS, CDC, EPO.

**Per 100,000 **

**2010 target**

**19-24 years**

**25-39 years**

**40 years and older**

**Asian or Pacific Islander **

**Hispanic**

**White, Not Hispanic**

**Black, Not Hispanic**

**Obj. 14-3**

## Rates of Tuberculosis

**2010 target**

**Rates of Tuberculosis**

- Note:  Data in parentheses represent the percent change in the rates between 1998 and 2001
- Source:  NTBSS, CDC, NCHSTP.

**2001**

**1998**

**American Indian or Alaska Native**

**Asian or Pacific Islander**

**Black, Not Hispanic**** **

**White, Not Hispanic**

**Hispanic**

**TOTAL**

**Obj. 14-11**

**Per 100,000 population**

**(-15%)**

**(-11%)**

**(-12%)**

**(-13%)**

**(-20%)**

**(-26%)**

## Proportion of Tuberculosis Patients Completing Curative Therapy

**Percent**

**2010 target**

**Proportion of Tuberculosis Patients Completing Curative Therapy**

- Source:  NTBSS, CDC, NCHSTP.

**1999**

**1996**

**American Indian or Alaska Native**

**Asian or Pacific Islander**

**Black, Not Hispanic**** **

**White, Not Hispanic**

**Hispanic**

**TOTAL**

**Obj. 14-12**

## Progress Review data and slides can be found on the web at: 

http://www.cdc.gov/nchs/hphome.htm

- _[http://www.cdc.gov/nchs/hphome.htm](http://www.cdc.gov/nchs/hphome.htm)_